You need JavaScript to view this

Incidence of leukemia in survivors of the atomic bomb in Hiroshima and Nagasaki, Japan

Technical Report:

Abstract

This document contains two reports. The aim of the first investigation was to obtain information concerning all individuals in Hiroshima and Nagasaki having onset of symptoms of leukemia or dying of the disease since the atomic explosion in 1945. Results show that: (1) There is a significant increase in the incidence of leukemia in the exposed populations of Hiroshima and Nagasaki as compared with the non-exposed populations of the two cities; (2) there is a significant increase in the incidence of leukemia within the exposed population of Hiroshima and Nagasaki in subjects exposed at distances less than 2000 meters from the hypocenter; and (3) The concept that radiation from the atomic bomb explosions in Hiroshima and Nagasaki is a leukemogenic agent in man is supported. In the second report, 10 patients were used to study the early hematologic and preclinical phases of leukemia in atomic bomb survivors. Findings are presented. 23 references, 13 figures, 15 tables.
Publication Date:
Jan 01, 1959
Product Type:
Technical Report
Report Number:
ABCC-30-59
Reference Number:
EDB-84-058035
Resource Relation:
Other Information: Portions are illegible in microfiche products
Subject:
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.; A-BOMB SURVIVORS; DELAYED RADIATION EFFECTS; LEUKEMIA; DOSE-RESPONSE RELATIONSHIPS; HEMATOLOGY; HIROSHIMA; NAGASAKI; PATHOGENESIS; RADIATION HAZARDS; ASIA; BIOLOGICAL EFFECTS; BIOLOGICAL RADIATION EFFECTS; DISEASES; HAZARDS; HEALTH HAZARDS; HEMIC DISEASES; HUMAN POPULATIONS; JAPAN; MEDICINE; NEOPLASMS; POPULATIONS; RADIATION EFFECTS; 560151* - Radiation Effects on Animals- Man; 560161 - Radionuclide Effects, Kinetics, & Toxicology- Man
OSTI ID:
5214556
Research Organizations:
Atomic Bomb Casualty Commission, Hiroshima (Japan)
Country of Origin:
Japan
Language:
Japanese and English
Contract Number:
AC01-76EV03081
Other Identifying Numbers:
Other: ON: DE84008422
Availability:
NTIS, PC A04/MF A01; 1.
Submitting Site:
HEDB
Size:
Pages: 56
Announcement Date:

Technical Report:

Citation Formats

Folley, J H, Borges, W, and Yamawaki, Takuso. Incidence of leukemia in survivors of the atomic bomb in Hiroshima and Nagasaki, Japan. Japan: N. p., 1959. Web.
Folley, J H, Borges, W, & Yamawaki, Takuso. Incidence of leukemia in survivors of the atomic bomb in Hiroshima and Nagasaki, Japan. Japan.
Folley, J H, Borges, W, and Yamawaki, Takuso. 1959. "Incidence of leukemia in survivors of the atomic bomb in Hiroshima and Nagasaki, Japan." Japan.
@misc{etde_5214556,
title = {Incidence of leukemia in survivors of the atomic bomb in Hiroshima and Nagasaki, Japan}
author = {Folley, J H, Borges, W, and Yamawaki, Takuso}
abstractNote = {This document contains two reports. The aim of the first investigation was to obtain information concerning all individuals in Hiroshima and Nagasaki having onset of symptoms of leukemia or dying of the disease since the atomic explosion in 1945. Results show that: (1) There is a significant increase in the incidence of leukemia in the exposed populations of Hiroshima and Nagasaki as compared with the non-exposed populations of the two cities; (2) there is a significant increase in the incidence of leukemia within the exposed population of Hiroshima and Nagasaki in subjects exposed at distances less than 2000 meters from the hypocenter; and (3) The concept that radiation from the atomic bomb explosions in Hiroshima and Nagasaki is a leukemogenic agent in man is supported. In the second report, 10 patients were used to study the early hematologic and preclinical phases of leukemia in atomic bomb survivors. Findings are presented. 23 references, 13 figures, 15 tables.}
place = {Japan}
year = {1959}
month = {Jan}
}